|
OSBPL1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.198000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.579500E-03 |
| Normal-vs-Stage2 |
4.473200E-01 |
| Normal-vs-Stage3 |
1.910260E-02 |
| Normal-vs-Stage4 |
1.67896999999639E-05 |
| Stage1-vs-Stage2 |
5.830200E-01 |
| Stage1-vs-Stage3 |
2.540800E-01 |
| Stage1-vs-Stage4 |
1.148050E-02 |
| Stage2-vs-Stage3 |
2.685400E-01 |
| Stage2-vs-Stage4 |
6.373600E-02 |
| Stage3-vs-Stage4 |
5.362200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.403800E-04 |
| Normal-vs-AfricanAmerican |
1.090640E-01 |
| Normal-vs-Asian |
3.949500E-02 |
| Caucasian-vs-AfricanAmerican |
2.945000E-01 |
| Caucasian-vs-Asian |
1.719970E-01 |
| AfricanAmerican-vs-Asian |
7.178200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.4076000000024E-05 |
| Normal-vs-Female |
2.338200E-01 |
| Male-vs-Female |
1.475980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.027500E-02 |
| Normal-vs-Extreme_Weight |
3.789400E-04 |
| Normal-vs-Obese |
3.281900E-02 |
| Normal-vs-Extreme_Obese |
9.103600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.646000E-01 |
| Normal_Weight-vs-Obese |
9.640400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.026000E-01 |
| Extreme_Weight-vs-Obese |
4.879800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.686000E-02 |
| Obese-vs-Extreme_Obese |
2.943400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.360600E-03 |
| Normal-vs-Age(41-60Yrs) |
7.356700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.444420E-03 |
| Normal-vs-Age(81-100Yrs) |
3.775000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.851230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.901000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.115000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.503000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.870200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.524000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.644400E-04 |
| Normal-VS-Type2 PRCC |
1.740630E-01 |
| Normal-VS-KIRP CIMP |
1.34850000055309E-08 |
| Normal-VS-Unclassified PRCC |
1.412780E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.146400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.208000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.111800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.208800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.479000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.018580E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.237300E-03 |
| Normal-vs-N1 |
9.51510000000155E-05 |
| Normal-vs-N2 |
4.22230000000079E-05 |
| N0-vs-N1 |
1.045640E-01 |
| N0-vs-N2 |
2.255200E-01 |
| N1-vs-N2 |
5.766400E-01 |
|
|
